In recent years, the incidence of hematological tumors in the central and western regions has increased year by year, which has attracted great attention from the medical community. Acute myeloid leukemia is more common in adults with acute leukemia, and acute lymphoblastic leukemia is more common in children. In order to bring more hope of treatment to leukemia patients, on May 30, the 2021 Blood Tumor Exchange Conference hosted by Chengdu High-tech Medical Association was held online.

The conference invited well-known domestic experts in pediatric hematology, tumor, immunity and related majors to give lectures, seminars and exchanges of academic papers. Professor Hong Mei from Union Hospital of Tongji Medical College of Huazhong University of Science and Technology expressed his warm welcome to the colleagues and firmly believes that with the joint efforts of the colleagues, the research of hematological tumors will surely develop further and vigorously.

At the end of the conference, Professor Li Xiaoming from the Affiliated Hospital of Southwest Medical University said that he believes that the convening of the Hematology and Tumor Exchange Conference of the High-tech Medical Association will promote the further development of hematological tumor-related disciplines in Chengdu and even the province, and contribute wisdom and strength to the cause of hematological tumors. , Benefit more patients.

This conference invites famous domestic experts in pediatric blood, tumor, immunology and related majors to give lectures. It is for the High-tech Medical Association to continue to implement the general secretary’s series of important instructions on people’s health and scientific and technological innovation, give full play to the organizational advantages of academic societies, and continuously improve academics Leading ability to promote the sustainable development of national health care is of great significance, and it also plays a major role in improving the level of treatment, scientific research and teaching in the fields of hematology and tumors.